top of page
Lab Work
N1’s dual-engine (peptide and polymer) powered technology platform is combined with its proprietary data-driven transporter discovery. Molecular transporters enable drug molecules of different sizes and properties to overcome biological barriers and drug resistance.
The company has established its fast-growing and sustainable model that utilizes the platform’s great and widely applicable potential for both its in-house pipelines and co-development partnerships. N1 Life’s R&D program covers areas from oncology to dermatology, ophthalmology, neurological diseases, and infectious diseases.
6accf7c9-60e6-4f6f-98e0-e29e9279b143_edited.png
bottom of page